Medical Xpress June 12, 2023
As adoption of Continuous Glucose Monitoring (CGM) continues to increase, there is a growing body of evidence supporting the use of this technology in improving diabetes outcomes for patients with type 1 or type 2 diabetes. A new supplement in the journal Diabetes Technology & Therapeutics (DTT) provides an excellent perspective of the past, present, and future of CGM.
In the supplement Rickson et al. review the rapid pace in which diabetes technology has progressed and the implications for relying on rigorous and extensive timelines to publish randomized controlled trials to impact provider awareness, clinical practice guidelines and insurance coverage. They propose alternative approaches to assessing the safety and efficacy of CGMs.
Gavin and Bailey review findings from recent real-world...
Today's Sponsors
Today's Sponsor